Long-term results of the treatment of Hodgkin’s lymphoma in a resource-constrained setting: Real-world data from a single center

Table 1 Salient features of 88 patients with Hodgkin´s lymphoma

Sex	Women	37 (42)
	Men	51 (57.9)
Age, yr	Median 29 (range: 5-73)
Type	Nodular sclerosing	62 (70)
	Mixed cellularity	19 (21.5)
	Lymphocyte depleted	2 (2.2)
	Lymphocyte predominant	1 (1.1)
Stage	Stage I	5 (5.6)
	Stage II	48 (54.5)
	Stage III	19 (1.5)
	Stage IV	16 (18.1)

Data are n (%)

Table 2 Salient features of patients who developed a secondary malignancy after the treatment of lymphoma

Neoplasm		Age	Sex	Type	Stage	Treatment	HSCT	Time1, mo
1	Tongue epidermoid carcinoma	32	M	Nodular sclerosing	I	Radiotherapy	No	58
2	Liver adenocarcinoma	22	F	Nodularsclerosing	III	MOPP	No	97
3	Breast cancer	38	F	Mixed cellularity	III	ABVD	No	150
4	NK/T-cell lymphoma	15	M	Nodular sclerosing	IV	ABVD	Autologous	18
5	Breast cancer	23	F	Nodular sclerosing	III	AVBD	Autologous	59

¹Time in months elapsed between the diagnosis of Hodgkin’s lymphoma and the diagnosis of the secondary neoplasia.

HSCT: Hematopoietic stem cell transplant; M: Male; F: Female.